| CLOSING SOON | Investment | I3-2026-INV1 | Interregional Innovation Investments | — | 2026-11-12 | N/A |
| CLOSING SOON | EIC Accelerator Open 2026 - Short proposal | HORIZON-EIC-2026-ACCELERATOR-01 | Horizon Europe | — | 2026-12-17 | N/A |
| CLOSING SOON | European Startup and Scaleup Hubs pilot | HORIZON-EIE-2027-02-CONNECT-01 | Horizon Europe | Grant | 2027-01-05 | 0–20M€ |
| OPEN | Valorising Horizon project results via innovation ecosystems | HORIZON-BRIDGING-2027-06-02 | Horizon Europe | Grant | 2027-02-16 | 2.5–4M€ |
| OPEN | Portable and versatile Point-of-care diagnostics | HORIZON-HLTH-2027-02-IND-02-two-stage | Horizon Europe | Grant | 2027-02-17 | 5–7M€ |
| OPEN | Addressing disabilities through the life course to support independent living and inclusion | HORIZON-HLTH-2027-01-STAYHLTH-01 | Horizon Europe | Grant | 2027-02-17 | 6–8M€ |
| OPEN | Integrating climate-related exposures into the human exposome and characterising its changes in response to climate change | HORIZON-HLTH-2027-01-ENVHLTH-02 | Horizon Europe | Grant | 2027-02-17 | 10–11M€ |
| OPEN | Tools and technologies to support health adaptation to climate change | HORIZON-HLTH-2027-01-ENVHLTH-MISSCLIMA-03 | Horizon Europe | Grant | 2027-02-17 | 4–5M€ |
| OPEN | Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications | HORIZON-HLTH-2027-01-CARE-02 | Horizon Europe | Grant | 2027-02-17 | 8–10M€ |
| OPEN | Development of cell-free protein synthesis platforms for discovery and/or production of biologicals | HORIZON-HLTH-2027-01-IND-01 | Horizon Europe | Grant | 2027-02-17 | 6–8M€ |
| OPEN | Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential | HORIZON-HLTH-2027-01-DISEASE-05 | Horizon Europe | Grant | 2027-02-17 | 9–11M€ |
| OPEN | Development of monoclonal antibodies to prevent and treat infections from Flaviviruses | HORIZON-HLTH-2027-01-DISEASE-06 | Horizon Europe | Grant | 2027-02-17 | 9–10M€ |
| OPEN | Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga viruses | HORIZON-HLTH-2027-01-DISEASE-07 | Horizon Europe | Grant | 2027-02-17 | 9–10M€ |
| OPEN | Prevention and management of chronic non-communicable diseases in children and young people (GACD) | HORIZON-HLTH-2027-01-DISEASE-10 | Horizon Europe | Grant | 2027-02-17 | 3–4M€ |
| OPEN | Development of innovative antimicrobials against pathogens resistant to antimicrobials | HORIZON-HLTH-2027-01-DISEASE-08 | Horizon Europe | Grant | 2027-02-17 | 8–10M€ |
| OPEN | Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases | HORIZON-HLTH-2027-02-TOOL-01-two-stage | Horizon Europe | Grant | 2027-02-17 | 6–8M€ |
| OPEN | Innovative healthcare interventions for non-communicable diseases | HORIZON-HLTH-2027-02-DISEASE-01-two-stage | Horizon Europe | Grant | 2027-02-17 | 7–8M€ |
| OPEN | Clinical trials for advancing innovative interventions for neurodegenerative diseases | HORIZON-HLTH-2027-02-DISEASE-14-two-stage | Horizon Europe | Grant | 2027-02-17 | 0–10M€ |
| OPEN | Excellence Hubs | HORIZON-WIDERA-2027-04-WIDENING-01 | Horizon Europe | Grant | 2027-03-04 | 1.5–4.5M€ |
| OPEN | Pillar II: Talent ecosystems for attractive early research careers | HORIZON-WIDERA-2027-05-ERA-02 | Horizon Europe | Grant | 2027-03-11 | 0–2M€ |
| OPEN | Pillar I: Facilitating development of institutional open access policies through the retention of intellectual property rights | HORIZON-WIDERA-2027-05-ERA-01 | Horizon Europe | Grant | 2027-03-11 | 0–2M€ |
| OPEN | Pillar III: Promoting public engagement in R&I and scientific literacy | HORIZON-WIDERA-2027-05-ERA-04 | Horizon Europe | Grant | 2027-03-11 | 0–1M€ |
| OPEN | Pillar III: Science comes to town 2029 | HORIZON-WIDERA-2027-05-ERA-03 | Horizon Europe | Grant | 2027-03-11 | 0–6M€ |
| OPEN | Pillar IV: Upgrading the EU’s independent knowledge on China's Science, Technology and Innovation system | HORIZON-WIDERA-2027-05-ERA-05 | Horizon Europe | Grant | 2027-03-11 | 0–3M€ |
| OPEN | Supporting the long-term resilience and European sovereignty of critical research data and knowledge repositories and scientific services for the life sciences | HORIZON-BRIDGING-2027-03-04 | Horizon Europe | Grant | 2027-06-15 | 0–8M€ |
| OPEN | ERA Fellowships | HORIZON-WIDERA-2027-03-WIDENING-01 | Horizon Europe | Grant | 2027-09-08 | 0.1–0.5M€ |
| OPEN | ERA Chairs | HORIZON-WIDERA-2027-02-WIDENING-01 | Horizon Europe | Grant | 2027-09-14 | 1.5–2.5M€ |
| OPEN | ERA Research Managers | HORIZON-WIDERA-2027-02-WIDENING-02 | Horizon Europe | Grant | 2027-09-14 | 1.5–2.5M€ |
| OPEN | Enhancing the involvement of philanthropic organisations in innovation ecosystems | HORIZON-EIE-2027-01-CONNECT-03 | Horizon Europe | Grant | 2027-09-15 | 0–1M€ |
| OPEN | Reinforcing synergies between experimentation spaces and innovation procurement | HORIZON-EIE-2027-01-CONNECT-02 | Horizon Europe | Grant | 2027-09-15 | 0–10M€ |
| OPEN | EIC Pre-accelerator - Widening | HORIZON-WIDERA-2027-01-WIDENING-01 | Horizon Europe | Grant | 2027-11-18 | 0.5–1M€ |
